News
Vancouver-based carbon dioxide removal projects company CO280 Solutions Inc. announced that it has signed a landmark CDR offtake agreement with US banking giant JPMorganChase.
AbCellera announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial Application (CTA) for ABCL635, an investigational antibody antagonist targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback